Cover Image

Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site

Saved in:

Bibliographic Details
Main Author:	Josef Finsterer (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2 vaccinations complicated by transverse myelitis
by: Josef Finsterer
Published: (2022)

The nature and severity of SARS-CoV-2 vaccine side effects in athletes are highly dependent on study design
by: Josef Finsterer, et al.
Published: (2023)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

Re-infections with SARS-CoV-2 require a clarification of favourable risk factors
by: Josef Finsterer
Published: (2023)

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
by: Josef Finsterer MD, PhD
Published: (2021)

SARS-CoV-2 variant-related abnormalities detected by prenatal MRI: direct or indirect effects of the infection must be demonstrated
by: Josef Finsterer
Published: (2023)

Neuro-COVID is a serious complication of SARS-CoV-2 infections and can determine the long-term outcome of COVID-19
by: Josef Finsterer
Published: (2022)

SARS-Cov-2 and Anti-COVID vaccines trigger Guillain-Barré syndrome
by: Josef Finsterer
Published: (2022)

Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
by: Josef Finsterer, et al.
Published: (2021)

Pilomatricoma growing at the SARS-CoV-2 mRNA vaccination site
by: Merve Hatun Erkayman, et al.
Published: (2023)

Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
by: J. Finsterer
Published: (2022)

SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
by: Rine Christopher Reuben, et al.
Published: (2021)

Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2
by: Char Leung
Published: (2021)

Assessing beneficial or side effects of COVID-vaccinations requires personal rather than electronic investigations
by: Josef Finsterer
Published: (2022)

Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
by: J. Finsterer, et al.
Published: (2023)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
by: Nawel Zammit, et al.
Published: (2022)

Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023)

T cells in SARS-CoV-2 infection and vaccination
by: Arthur Young
Published: (2022)

Real-world assessment of reinfection with SARS-CoV-2: Implications for vaccines
by: Kuang-Hung Tseng, et al.
Published: (2025)

Pandemic Preparedness: The Potential Advantage of Medicines That Prevent Acute Side Effects of Vaccination, SARS-CoV-2 as an Example
by: Pantea Kiani, et al.
Published: (2022)

Promising on-site and rapid SARS-CoV-2 detection via antigens
by: Jian Zhang, et al.
Published: (2022)

Vaccine safety - is the SARS-CoV-2 vaccine any different?
by: Noam Tau, et al.
Published: (2021)

How Long Should the Prone Position be Applied in the Treatment of SARS-CoV-2 ARDS?
by: Tuğba Yücel, et al.
Published: (2024)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023)

Vitiligo Repigmentation After SARS-CoV-2 Vaccine
by: Roberto Bustos-Macaya, et al.
Published: (2023)

Alopecia areata after SARS-CoV-2 vaccination
by: Margaret E. Scollan, MSc, et al.
Published: (2022)

Pregnancy and SARS - CoV - 2 vaccination: Unraveling the myths
by: Anita Yadav, et al.
Published: (2021)

SARS-CoV-2 reinfection and implications for vaccine development
by: Firzan Nainu, et al.
Published: (2020)

SARS-CoV-2 vaccine candidates in rapid development
by: Lifeng Li, et al.
Published: (2021)

SARS-CoV-2 Vaccination for Children-An Open Issue
by: Désirée Caselli, et al.
Published: (2021)

Assessing the risks of SARS-CoV-2 in wildlife
by: R. J. Delahay, et al.
Published: (2021)

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
by: Nawfal R. Hussein, et al.
Published: (2022)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022)

Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
by: John T. Bates, et al.
Published: (2024)

Rare lymphomatoid reactions following SARS-CoV-2 vaccination
by: Tessa LeWitt, BS, et al.
Published: (2022)

Development of Schamberg's disease after SARS‐CoV‐2 vaccination
by: Hiroki Morimoto, et al.
Published: (2022)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
by: Sandra Hasmann, et al.
Published: (2021)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
by: Utkarsh Srivastava, et al.
Published: (2022)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
by: Michael Levin, et al.
Published: (2022)